You L - Search Results

1

The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins.

You L, Liu H, Huang J, Xie W, Wei J, Ye X, Qian W. You L, et al. Oncotarget. 2017 Jan 31;8(5):7777-7790. doi: 10.18632/oncotarget.13951. Oncotarget. 2017. PMID: 27999193 Free PMC article.

2

Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*.

Meng HT, Zhu L, Ni WM, You LS, Jin J, Qian WB. Meng HT, et al. Among authors: you ls. Acta Pharmacol Sin. 2011 Apr;32(4):503-11. doi: 10.1038/aps.2010.237. Epub 2011 Mar 28. Acta Pharmacol Sin. 2011. PMID: 21441948 Free PMC article.

3

Downregulation of Mcl-1 synergizes the apoptotic response to combined treatment with cisplatin and a novel fiber chimeric oncolytic adenovirus.

You L, Wang Y, Jin Y, Qian W. You L, et al. Oncol Rep. 2012 Apr;27(4):971-8. doi: 10.3892/or.2012.1636. Epub 2012 Jan 16. Oncol Rep. 2012. PMID: 22266706 Free PMC article.

4

Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro.

Tong Y, Liu YY, You LS, Qian WB. Tong Y, et al. Acta Pharmacol Sin. 2012 Apr;33(4):542-50. doi: 10.1038/aps.2011.192. Epub 2012 Mar 12. Acta Pharmacol Sin. 2012. PMID: 22407228 Free PMC article.

5

[ITF-2357 on inhibition myeloid leukemic cell lines cells proliferation in vitro and its mechanism].

Yu WJ, Wang L, You LS, Mei C, Ma QL, Jin J. Yu WJ, et al. Among authors: you ls. Zhonghua Xue Ye Xue Za Zhi. 2012 May;33(5):366-70. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22781793 Chinese.

6

[Synergistic effect of histone deacetylase inhibitor suberoylanilide hydroxamic acid with imatinib on K562 cells].

Liu YY, You LS, Qian WB, Tong Y. Liu YY, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 Sep;41(5):473-8. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 23086637 Chinese.

7

SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt.

Meng H, Jin Y, Liu H, You L, Yang C, Yang X, Qian W. Meng H, et al. Among authors: you l. J Hematol Oncol. 2013 Feb 18;6:18. doi: 10.1186/1756-8722-6-18. J Hematol Oncol. 2013. PMID: 23415012 Free PMC article.

8

Homoharringtonine and SAHA synergistically enhance apoptosis in human acute myeloid leukemia cells through upregulation of TRAIL and death receptors.

Cao H, Cheng Y, You L, Qian J, Qian W. Cao H, et al. Among authors: you l. Mol Med Rep. 2013 Jun;7(6):1838-44. doi: 10.3892/mmr.2013.1440. Epub 2013 Apr 25. Mol Med Rep. 2013. PMID: 23620163

9

Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia.

Tong Y, You L, Liu H, Li L, Meng H, Qian Q, Qian W. Tong Y, et al. Among authors: you l. Oncotarget. 2013 Jun;4(6):860-74. doi: 10.18632/oncotarget.1018. Oncotarget. 2013. PMID: 23765161 Free PMC article.

10

PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus.

Tong Y, Zhu W, Huang X, You L, Han X, Yang C, Qian W. Tong Y, et al. Among authors: you l. Oncol Rep. 2014 Apr;31(4):1581-8. doi: 10.3892/or.2014.3020. Epub 2014 Feb 11. Oncol Rep. 2014. PMID: 24535016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,607 results

Search Page

Filters